CLINICAL_TRIALS
trial_result
· 2018-04-04
Clinical Trial Update: A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Summary
A Phase 1 dose-escalation study of RO6874813 was conducted in participants with locally advanced or metastatic solid tumors. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 1 | Status: COMPLETED